HealthPrize Teams Up with RealAge to Improve Adherence High Engagement in Reward Program Among Asthma/COPD Patients
Unless taken, medicines don’t work. That’s how Michael Rosenblatt, M.D., Chief Medical Officer at Merck, expressed it in a comment to a Wall Street Journal Health blog post. Lack of medication adherence is a major issue contributing to poor health outcomes and higher costs.
“The challenge in changing such behavior is complex, but finding ways to improve patient adherence is a win-win situation for everyone involved in healthcare,” noted Dr. Rosenblatt. “There has never been a better time, nor time of greater need. Now is the time for all of us — patients, doctors, pharmacists, government, insurers, employers and the pharmaceutical industry — to work to solve this problem,” said Dr. Rosenblatt.
HealthPrize Technologies believes it has at least part of the solution, which is to provide an innovative approach with an online and mobile-based program that is fun, engaging and educational.
This article summarizes the results of a six-month asthma and chronic obstructive pulmonary disease (COPD) pilot study in which HealthPrize partnered with RealAge to test patient engagement with the HealthPrize online and mobile platform.
Topics include:
- The healthcare costs associated with non-adherence
- So why is it so difficult to improve adherence?
- Treat People Like People, Not Patients
- The HealthPrize Model
- High Engagement Among Asthma/COPD Patients
- Lessons Learned
Download full article (PDF)
PMN113-01
Issue: Vol. 11, No. 3
Publication date: 19 March 2012
Word Count: 1,852
Find other articles in related Topic Areas:
